Today in Healthcare
SEE OTHER BRANDS

Fresh news on healthcare in the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Healthcare.

MOH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Deadline Alert: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Intelligent Process Automation Powers Record Efficiency Across U.S. Healthcare Systems
Intelligent Process Automation Accelerates Digital Transformation Across U.S. Healthcare
MedPro Healthcare Staffing Named Top Corporate Team of the Year for Light The Night, South Florida, Raising $37,255 to Support the Leukemia & Lymphoma Society
Protein Engineering Market to Grow at 16.27% CAGR by 2034, Driven by Rising Outsourcing and Expanding Healthcare Applications
Single-Cell Omics Market to Reach USD 12.05 Billion by 2034, Growing at a 16.14% CAGR | Towards Healthcare
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
Project C.U.R.E. Bridge the Global Healthcare Divide with Mission-Driven Innovation with Microsoft
Outset Medical to Present at the 2025 Stifel Healthcare Conference
MOLINA CLASS ACTION LAWSUIT: Molina Healthcare, Inc. (NYSE:MOH) Investors with Losses are Notified of the Upcoming December 2 Court Deadline – Contact BFA Law
OTSAW Enters Japanese Market with Moraine Corporation with Aim to Revolutionize Hospital Operations Through Robotics
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions